Loading...
Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: An observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial
Preiss, David Thomas, Laine E. Sun, Jie-Lena Haffner, Steven M. Holman, Rury R. Standl, Eberhard Leiter, Lawrence A. Mazzone, Theodore Rutten, Guy E. Tognoni, Gianni
Preiss, David
Thomas, Laine E.
Sun, Jie-Lena
Haffner, Steven M.
Holman, Rury R.
Standl, Eberhard
Leiter, Lawrence A.
Mazzone, Theodore
Rutten, Guy E.
Tognoni, Gianni
Abstract
Objectives: Risk factors for cardiovascular events are well established in general populations and those with diabetes but have been sparsely studied in impaired glucose tolerance (IGT). We sought to identify predictors of (1) a composite cardiovascular outcome (cardiovascular death, non-fatal myocardial infarction and non-fatal stroke) and (2) cardiovascular death, among patients with IGT.
Keywords
Date
2012
Type
Journal article
Journal
BMJ Open
Book
Volume
2
Issue
6
Page Range
1-10
Article Number
ACU Department
Collections
Relation URI
Source URL
Event URL
Open Access Status
Published as ‘gold’ (paid) open access
License
File Access
Open
Notes
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.